The new European Medicines Agency guideline on antidepressants: a guide for researchers and drug developers

The new European Medicines Agency guideline on antidepressants: a guide for researchers and drug developers

According to the World Health Organization (WHO), depressive disorders are currently considered as one of the most disabling medical conditions in the world with one of the highest disability-adjusted life years [1] and this situation has apparently been further worsened during the COVID-19 pandemic...

Full description

Bibliographic Details
Main Authors: Florence Butlen-Ducuing, Marion Haberkamp, Georgios Aislaitner, Ewa Bałkowiec-Iskra, Taina Mattila, Marika Doucet, Marta Kollb-Sielecka, Pavel Balabanov, Ann-Kristin Leuchs, André Elferink
Format: Article
Language:English
Published: Cambridge University Press 2024-01-01
Series:European Psychiatry
Subjects:
Depression
medicines
Clinical trial
innovation
EMA
Online Access:https://www.cambridge.org/core/product/identifier/S0924933823024793/type/journal_article

Similar Items

Similar Items